Professor Tim Lambert

Professor of Psychiatry
Psychiatry, Concord Clinical School
Brain & Mind Research Institute

C22 - Concord Hospital
The University of Sydney
NSW 2006 Australia

T:	+61 2 9351 0721 (mon & fri); 9767 7161 (tues-thurs)
F:	+61 2 97677107
E:

Biographical details

Tim Lambert, BSc, MBBS, PhD, FRANZCP, is Professor of Psychiatry at Concord Clinical School at The University of Sydney in Australia. He also holds an appointment as Head of Schizophrenia Treatment and Outcomes Research at the Brain & Mind Research Institute in Sydney. In addition, he fulfils clinical duties for Sydney Local Health Network as Director of the Centre of Excellence in Relapse Prevention in Psychosis (CERP), and at the Concord Centre for Cardiometabolic Health in Psychosis (ccCHiP). [More...]

Professor Lambert has a portfolio of interests in translational aspects of clinical neuropharmacology and neurosciences. These span clinical psychosis research, outcomes research, service delivery models, training, and education. His current interests focus on services research (pharmacoepidemiology, developing novel relapse prevention, treatment resistance, and cardiometabolic services for the seriously mentally ill); the clinical pharmacology of LAI antipsychotics (first and second generation) and of the second-generation antipsychotics, particularly risk-benefit aspects and the applied clinical pharmacology of antipsychotic switching; physical comorbidities of psychotic disorders, especially cardiometabolic syndromes; and incomplete recovery. Social aspects, particularly the role of acculturation on clinical phenotypes permeate all facets of these programmes. In terms of education and training, his team has been developing newmedia-based approaches to education and this work has been utilised to produce educational and training materials such as CD-ROMs, DVDs and web-based applications for mental health workers in many parts of the world.

He has been a principal in the development of a number of clinical practice guidelines, algorithms, and consensus documents (Diabetes and antipsychotics; RANZCP CPG for schizophrenia; Treatment Refractory Consensus Guidelines, for example). Professor Lambert is a regularly invited lecturer, clinical trainer, and consultant throughout Asia, Australia, Europe, and North America. He is a member of a number of international and national advisory groups concerned with antipsychotic treatments and their role in community psychiatry. [Hide detail]

Research interests

Schizophrenia

Cardiometabolic Illness in psychosis

Treatment resistance

Psychopharmacology of psychosis

Community psychiatry

Relapse Prevention

Newmedia education strategies

Teaching areas

Undergraduate:

Schizophrenia (especially treatments, side effects); psychopathology and introduction to descriptive phenomenology;

Postgraduate:

All aspects of schizophrenia and related neurosciences; cross discipline approaches to improvement in psychosis outcomes

Keywords

Pharmacology; Cardiovascular diseases; Schizophrenia; Diabetes

International links

United States. (Albert Einstein College of Medicine) Collaborative international education on relapse prevention as part of the CERP initiative.
Germany. (Munich Technical University) International educational collaboration for relapse prevention.

Publications

2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007

2013

Chen, R., Lambert, T. (2013), Managing cardiovascular risk factors in people with serious mental illness: the tragedy of neglect. Endocrinology Today. 2(1), 25-27.

2012

Feiler, G., Chen, R., Pantelis, C., Lambert, T. (2012), Health behaviours of community-treated patients with psychosis. Australasian Psychiatry. 20(3), 208-213. [Abstract]
O'Connor, N., Mulley, R., Grasso, B., Lambert, T., Snars, J., Jhita, P. (2012), An Acute Recovery Unit: the first 18 months. Australasian Psychiatry. 20(3), 214-219. [Abstract]
Robillard, R., Rogers, N., Whitwell, B., Lambert, T. (2012), Are Cardiometabolic and Endocrine Abnormalities Linked to Sleep Difficulties in Schizophrenia? A Hypothesis Driven Review. Clinical Psychopharmacology and Neuroscience. 10(1), 1-12.
Robillard, R., Lambert, T., Rogers, N. (2012), Measuring sleep¿wake patternswith physical activity and energyexpenditure monitors. Biological Rhythm Research. 43(5), 555-562.
Lambert, T., Emmerson, B., Hustig, H., Resseler, S., Jacobs, A., Butcher, B. (2012), Long acting risperidone in Australian patients with chronic schizophrenia: 24-month data from the e-STAR database. BMC Psychiatry. 12(1), 25. [Abstract]

2011

Happell, B., Platania-Phung, C., Gray, R., Hardy, S., Lambert, T., McAllister, M., Davies, C. (2011), A role for mental health nursing in the physical health care of consumers with severe mental illness. Journal of Psychiatric and Mental Health Nursing. 18(8), 706-711. [Abstract]
Lambert, T., Taylor, D. (2011), Pharmacology of antipsychotic long-acting injections. In: Antipsychotic Long-acting injections. (pp.23-46).United Kingdom: Oxford University Press.
McGorry, P., Cocks, J., Power, P., Burnett, P., Harrigan, S., Lambert, T. (2011), Very Low-Dose Risperidone in First-Episode Psychosis: A Safe andEffective Way to Initiate Treatment. Schizophrenia Research and Treatment. 2011, 631690.
Kelin, K., Lambert, T., Brnabic, A., Newton, R., Ye, W., Escamilla, R., Chen, K., Don, L., Montgomery, W., Karagianis, J., Ascher-Svanum, H. (2011), Treatment discontinuation and clinical outcomes in the 1-year naturalistic treatment of patients with schizophrenia at risk of treatment nonadherence. Patient Preference and Adherence. 5, 213-222. [Abstract]
Dalton, A., Lambert, T., Schrover, R., Hertel, J., Smith, D. (2011), The cost associated with administering risperidone long-acting injections in the Australian community. BMC Health Services Research. 11, 236. [Abstract]
Lambert, T. (2011), Managing the metabolic adverse effects of antipsychotic drugs in patients with psychosis. Australian Prescriber. 34(4), 97-99.
Lambert, T., Olivares, J., Peuskens, J., Desouza, C., Kozma, C., Otten, P., Crivera, C., Jacobs, A., Macfadden, W., Mao, L., Rodriguez, S., Dirani, R., Akhras, K. (2011), Effectiveness of injectable risperidone long-acting therapy for schizophrenia: data from the US, Spain, Australia, and Belgium. Annals of General Psychiatry. 10, 10. [Abstract]
Lambert, T. (2011), Prescribing patterns and determinants of use of antipsychotic long-acting injections: an international perspective. In: Antipsychotic Long-acting Injections. (pp.209-230).United Kingdom: Oxford University Press.
Patel, M., Matonhodze, J., Baig, M., Gilleen, J., Boydell, J., Holloway, F., Taylor, D., Szmukler, G., Lambert, T., David, A. (2011), Increased use of antipsychotic long-acting injections with community treatment orders. Therapeutic Advances in Psychopharmacology. 1(2), 37.
Haddad, P., Lambert, T., Lauriello, J. (2011), The role of antipsycholtic long-acting injections in current practice. In: Antipsychotic Long-acting injections. (pp.241-260).United Kingdom: Oxford University Press.

2010

Guastella, A., Einfeld, S., Gray, K., Rinehart, N., Tonge, B., Lambert, T., Hickie, I. (2010), Intranasal Oxytocin Improves Emotion Recognition for Youth with Autism Spectrum Disorders. Biological psychiatry. 67(7), 692-4. [Abstract]
Lambert, T. (2010), Office for Psychiatric Evaluation and New Media (open). In: The Department of Psychiatry at the University of Melbourne 1964-2009: Personal Reminiscences. (pp.130-134).Australia: University of Melbourne.
Lambert, T. (2010), Disease Management: MultidimensionalApproaches to Incomplete Recovery inPsychosis. In: Advances in Biological Psychiatry: Therapy-Resistant Schizophrenia. (pp.87-113).Basel (Switzerland): S. Karger AG,.

2009

Lambert, T., Singh, B., Patel, M. (2009), Community treatment orders and antipsychotic long-acting injections. British Journal of Psychiatry. 195(52), S57-S62. [Abstract]
Lambert, T. (2009), Switching to aripiprazole from olanzapine leads to weight loss in overweight people with schizophrenia or schizoaffective disorder. Evidence - Based Mental Health. 12(2), 50. [Abstract]
Lambert, T., Newcomer, J. (2009), Are the cardiometabolic complications of schizophrenia still neglected? Barriers to care. Medical Journal of Australia. 190(4 Suppl), S39-S42. [Abstract]
Lambert, T. (2009), The medical care of people with psychosis. Medical Journal of Australia. 190, 171-172. [Abstract]
Addington, J., Lambert, T., Burnett, P. (2009), Complete and incomplete recovery from first-episode psychosis. In: The Recognition and Management of Early Psychosis: A Preventive Approach. (pp.201-222).United Kingdom: Cambridge University Press.

2008

Walter, G., Delaroche, A., Soh, N., Hunt, G., Cleary, M., Malhi, G., Lambert, T., Correll, C., Rey, J. (2008), Side effects of second-generation antipsychotics: the experiences, views and monitoring practices of Australian child psychiatrists. Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists. 16(4), 253-62. [Abstract]
Sundram, S., Lambert, T., Piskulic, D. (2008), Acculturation is associated with the prevalence of tardive dyskinesia and akathisia in community-treated patients with schizophrenia. Acta psychiatrica Scandinavica. 117(6), 474-478. [Abstract]
Lauriello, J., Lambert, T., Andersen, S., Lin, D., Taylor, C., McDonnell, D. (2008), An 8-Week, Double-Blind, Randomized, Placebo-Controlled Study of Olanzapine Long-Acting Injection in Acutely Ill Patients With Schizophrenia. The Journal of clinical psychiatry. 69(5), 790-9. [Abstract]
Lambert, T., Norman, T. (2008), Ethnic differences in psychotropic drug response and pharmacokinetics. In: Ethno-psychopharmacology: Advances in Current Practice. (pp.38-61).United Kingdom: Cambridge University Press.

2007

Iqbal, N., Lambert, T., Masand, P. (2007), Akathisia: problem of history or concern of today. CNS spectrums. 12(9 Suppl 1), 1-13. [Abstract]
Elsom, S., Happell, B., Manias, E., Lambert, T. (2007), Expanded practice roles for community mental health nurses: a qualitative exploration of psychiatrists' views. Australasian Psychiatry. 15(4), 324-328. [Abstract]
Subramaniam, M., Ng, C., Chong, S., Mahendran, R., Lambert, T., Pek, E., Huak, C. (2007), Metabolic differences between Asian and Caucasian patients on clozapine treatment. Human psychopharmacology. 22(4), 217-222. [Abstract]
Weiden, P., Miller, A., Lambert, T., Buckley, P. (2007), The art and science of switching antipsychotic medications, part 2. The Journal of clinical psychiatry. 68(1), e02. [Abstract]
Lambert, T. (2007), Switching antipsychotic therapy: what to expect and clinical strategies for improving therapeutic outcomes. The Journal of clinical psychiatry. 68(Suppl 6), 10-13. [Abstract]
Berk, M., Fitzsimons, J., Lambert, T., Pantelis, C., Kulkarni, J., Castle, D., Ryan, E., Jespersen, S., McGorry, P., Berger, G., Kuluris, B., Callaly, T., Dodd, S. (2007), Monitoring the safe use of clozapine: a consensus view from Victoria, Australia. CNS drugs. 21(2), 117-127. [Abstract]

The University of Sydney - Brain and Mind Research Institute